Home › Dermatomyositis › Florida › Miami
Dermatomyositis clinical trials in Miami, FL
4 studies for Dermatomyositis are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
RecruitingPhase 3
- Research Site, Miami
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
RecruitingPhase 3
- University of Miami, Miami
- University of Miami Dermatology Clinical Trials Unit, Miami
- University of Miami, Miami
- and 1 more
Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
RecruitingPhase 2
- University of Miami Hospital and Clinics, Miami
Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
RecruitingPhase 2/3
- Bioresearch Partner, Miami
Dermatomyositis trials in other cities
- Durham, NC8 studies
- Washington, DC7 studies
- New York City, NY5 studies
- Pittsburgh, PA5 studies
- Houston, TX5 studies
- Boston, MA5 studies
- Baltimore, MD4 studies
- Philadelphia, PA4 studies
- Phoenix, AZ3 studies
- Aurora, CO3 studies
- Kansas City, KS3 studies
- Jacksonville, FL3 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer27 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
- Metastatic Cancer23 studies
- Overweight23 studies
- Ulcerative Colitis22 studies
- Alzheimer's Disease21 studies
- Multiple Myeloma21 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.